A night of elegance and commitment. Celebrating 30 years of the Diplomatic Association of Panama in collaboration with Lanco Medical Group. Honoring the charitable work of the ADP and its...
Through our Medical Supply subsidiary Alcala Pharma, we attended this event where we held strategic meetings with the most important suppliers in Asia, Europe and the United States.
Recently, representatives of Lanco Medical Group, a Colombian pharmaceutical company, expressed their interest in executing projects in the country due to the decrease in crime rates and the increase...
The announcement of TopAlliance Biosciences, a wholly-owned subsidiary of Junshi Biosciences of FDA approval of LOQTORZI™ (toripalimab-tpzi), marks a success in the treatment of nasopharyngeal carcinoma (NPC). This treatment,...
In a significant stride toward advancing healthcare solutions, Lanco Medical Group and Aurobindo, two stalwarts in the medical industry, have joined forces in a groundbreaking partnership. This strategic alliance...
Today, we are thrilled to share the latest milestone in our partnership – the launch of groundbreaking cardiovascular and cardiometabolic products across Central America! Innovation That Inspires: Nobel Pharmaceuticals,...
[Miami, 2023.10.18] – Venipharm,a leading French pharmaceutical company specializing in generics and pharmaceutical development, has announced a groundbreaking strategic partnership with Lanco Medical Group, a renowned player in the...
We are thrilled to announce a groundbreaking partnership that is reshaping the landscape of healthcare in Central America. Through our strategic alliance with Zydus Lifesciences, we are introducing top-tier...
©2023 Lanco Medical Group
All Rights Reserved.
